Medical research

Nanobody-drug conjugates hijack the human vitamin B12 uptake route

A major challenge in cancer therapy is selectively targeting cancer cells over healthy ones. A recent study by the Locher group (IMBB) describes the development of camelid single-domain antibodies (nanobodies) that selectively ...

Neuroscience

Better hearing with optical cochlear implants

Cochlear implants enable people with profound hearing impairment to gain a great deal in terms of quality of life, including understanding spoken words and developing normal speech. However, background noises are problematic; ...

Oncology & Cancer

Tracking tumor cells and unraveling hidden information

tumor cells circulating in the blood of cancer patients are important markers for early diagnosis, treatment success and patient prognosis. But since so few circulate, identifying them is a challenge. Thanks to artificial ...

Medical research

Investigators lead effort to create map of the human kidney

Diabetes is the leading cause of end-stage renal disease, one of the nation's most debilitating and expensive medical conditions. In 2016 Medicare spent $35 billion caring for more than 725,000 Americans whose kidneys had ...

Ophthalmology

Confocal microscopy aids surgical removal of tumors from eyelid

(HealthDay)—Imaging using fluorescence confocal microscopy (FCM) analysis in the reflectance mode and with an "en face" scanning can control tumor margins of eyelid basal cell carcinoma (BCC) to optimize surgical management, ...

Diseases, Conditions, Syndromes

New technique opens the door to development of osteoperosis drugs

Scientists from the University of Granada (UGR) have opened the door to the development of new drugs against osteoporosis, one of the most common chronic illnesses in the world, especially among women 65 or over.

page 2 from 4